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Abstract: Microorganisms are able to form biofilms within respiratory secretions. Methods
to disaggregate such biofilms before utilizing standard, rapid, or high throughput diagnostic
technologies may aid in pathogen detection during ventilator associated pneumonia (VAP) diagnosis.
Our aim was to determine if sonication of endotracheal aspirates (ETA) would increase the sensitivity
of qualitative, semi-quantitative, and quantitative bacterial cultures in an animal model of pneumonia
caused by Pseudomonas aeruginosa or by methicillin resistant Staphylococcus aureus (MRSA). Material
and methods: P. aeruginosa or MRSA was instilled into the lungs or the oropharynx of pigs in order
to induce severe VAP. Time point assessments for qualitative and quantitative bacterial cultures of
ETA and bronchoalveolar lavage (BAL) samples were performed at 24, 48, and 72 h after bacterial
instillation. In addition, at 72 h (autopsy), lung tissue was harvested to perform quantitative bacterial
cultures. Each ETA sample was microbiologically processed with and without applying sonication
for 5 min at 40 KHz before bacterial cultures. Sensitivity and specificity were determined using BAL
as a gold-standard. Correlation with BAL and lung bacterial burden was also determined before
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and after sonication. Assessment of biofilm clusters and planktonic bacteria was performed through
both optical microscopy utilizing Gram staining and Confocal Laser Scanning Microscopy utilizing
the LIVE/DEAD®BacLight kit. Results: 33 pigs were included, 27 and 6 from P. aeruginosa and
MRSA pneumonia models, respectively. Overall, we obtained 85 ETA, 69 (81.2%) from P. aeruginosa
and 16 (18.8%) from MRSA challenged pigs. Qualitative cultures did not significantly change
after sonication, whereas quantitative ETA cultures did significantly increase bacterial counting.
Indeed, sonication consistently increased bacterial burden in ETAs at 24, 48, and 72 h after bacterial
challenge. Sonication also improved sensitivity of ETA quantitative cultures and maintained
specificity at levels previously reported and accepted for VAP diagnosis. Conclusion: The use
of sonication in ETA respiratory samples needs to be clinically validated since sonication could
potentially improve pathogen detection before standard, rapid, or high throughput diagnostic
methods used in routine microbial diagnostics.
Keywords: biofilm; endotracheal aspirate; sonication; ventilator associated pneumonia; animal model;
Pseudomonas aeruginosa; Staphylococcus aureus
1. Introduction
Ventilator associated pneumonia (VAP) may occur after 48 h of oro-tracheal intubation with
a pooled mean incidence of 10 episodes for 1000 ventilator-days, becoming one of the principal
Intensive Care Unit (ICU)-acquired infections worldwide [1–3]. Accurate and rapid diagnostic methods
are key to initiate appropriate antimicrobial treatment and to reduce VAP relapse, healthcare costs,
mortality, and an indirect effect on the emergence of bacterial resistance [4–6]. A wide new panel of
rapid diagnostic technologies offers promising possibilities for the optimization of antibiotics usage [7].
However, adequate implementation of these novel technologies is an important consideration as they
also present limitations. A notable limitation of these technologies is that they provide an important
amount of raw data that requires qualified interpretation before clinical decision making. Furthermore,
new unexpected limitations may emerge as these new technologies become routinely implemented.
Current strategies for microbiological diagnosis of VAP include the microbiological culture of
one of the following respiratory samples: endotracheal aspirate (ETA), bronchoalveolar aspirate
(BAS), bronchoalveolar lavage (BAL), and protected specimen brush (PSB). The cut-off for bacterial
growth to differentiate between colonization and infection are 5 or 6 log CFU/mL for ETA and BAS,
4 log CFU/mL for BAL, and 3 log CFU/mL for PSB [7–9]. BAL is probably the most representative
respiratory sample for diagnosing VAP. The reason for this is not only the extensive area of alveoli
explored, but also the quality of the samples obtained. This allows the detection of intracellular
organisms, rapid molecular techniques, rapid stains, and qualitative or quantitative cultures [10].
The use of ETA instead of BAL has been associated with VAP over-diagnosis, without any impact
on VAP clinical outcomes [9,11–13]. ETA and BAL cultures offer good positive and negative
predictive values for VAP diagnosis when utilized before antibiotics administration or change of
treatment. Nevertheless, differentiation between colonization and infection remains a limitation of both
semi-quantitative cultures and rapid diagnostic tools. An integrated approach that balances clinical
judgment and microbiological results is likely the best approach for VAP diagnosis and treatment [14].
There is consistent evidence that microorganisms can grow in biofilms within respiratory
secretions, because mucus stimulates biofilm production [15–17]. Biofilm associated infections (BAI)
are of great clinical concern because the biofilm’s mode of growth is responsible for culture negative
results, recalcitrance to antimicrobial treatment, and emergence of antimicrobial resistance [18,19].
Therefore, it is challenging to implement diagnostic tools without misleading diagnostics of BAI.
In a landmark study, Trampuz et al. (2007) demonstrated that sonication of the sample significantly
increased the sensitivity and specificity of bacterial cultures for diagnosis of biofilm-associated
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prosthetic joint infections [20]. Sonication of fluids containing the sample was recommended in
the latest clinical guidelines for the treatment and management of BAI, especially for catheter and
prosthetic related infections [21]. However, studies are lacking on the utility of sonication of respiratory
samples to improve VAP diagnosis.
Recent investigations have demonstrated the presence of biofilm aggregates in BAL samples
from children with non-cystic fibrosis bronchiectasis by confocal laser scanning microscopy
(CLSM) [22]. We previously demonstrated the presence of biofilm aggregates growing directly
attached to the internal surface of endotracheal tubes (ETT) and/or associated within host respiratory
secretions in an animal model of either methicillin resistant Staphylococcus aureus (MRSA) or
Pseudomonas aeruginosa [23,24].
We hypothesized that sonication of the ETA would increase bacterial release from biofilm
aggregates, thus improving the sensitivity and specificity of VAP microbiological diagnosis. In this
study, we compared bacterial qualitative, semi-quantitative, and quantitative cultures before and after
ETA sonication in an animal model of pneumonia, to determine sonication’s effect on the sensitivity
and specificity of bacterial cultures and any improvement between ETA and lung bacterial growth
correlation after ETA sonication.
2. Material and Methods
2.1. Population
All endotracheal aspirates from several ongoing porcine studies of VAP and severe pneumonia
caused by either Pseudomonas aeruginosa or MRSA were included.
P. aeruginosa or MRSA cultures were instilled into the lungs or the oropharynx to induce
severe or ventilator-associated pneumonia in anesthetized, orotracheally intubated, and mechanically
ventilated pigs, respectively [25,26]. Both models have been previously validated by our group and
the primary difference is that the bronchial challenge rapidly develops severe pneumonia whilst
the oropharynx instillation closely mimics the pathophysiology of VAP [25–27]. Briefly, in the
first model, 75 mL of 7 log CFU/mL of a log-phase culture (Luria Broth (LB), OD600nm = 0.1–0.2)
was instilled into the lungs, whereas in the second model, 5 mL of 7 log CFU/mL of a log-phase
culture was instilled twice into the oropharynx. Animals were kept mechanically ventilated and were
euthanized seventy-two hours after bacterial challenge. The institutional review board and animal
ethics committee approved all included studies. The project license number that covered the animal
experiments was the following: 06/17. 9322 (start date 14/12/16 and the expiration date 28/03/19).
Animals were managed according to the National Institutes of Health guidelines for the Use and
Care of Animals. Additional details on animal handling and methods are reported in previous
publications [26].
2.2. Collection of Samples
Paired ETA and BAL were obtained sequentially at 24, 48, and 72 h after bacterial instillation to
perform qualitative, semi-quantitative, and quantitative bacterial cultures in each animal. Tracheal
suctioning was performed using a 12-Fr standard CSS (KIMVENT* Closed Suction Systems,
Kimberly Clark, Irving, TX, USA), as clinically recommended [28]. BAL was performed using
a bronchoscope (Pentax SAFE-3000; Ricoh Imaging Deutschland GmbH, Hamburg, Germany) in
the right medium lobe with two 10-mL aliquots of sterile saline solution. The first aliquot was
discarded, while the second one was used for quantitative microbiology studies. Pigs were euthanized
after 72 h of bacterial challenge and lung tissue samples were harvested to assess quantitative cultures.
2.3. Microbiological Analysis
ETA and BAL were liquified in sterile 0.9% saline solution (NaCl), homogenized with a vortex
mixer and then serially diluted by aseptic transfer of 0.1 mL samples into 0.9 mL of sterile 0.9% NaCl
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solution to yield dilutions of 10−1 to 10−3-fold on blood and MacConkey agar and incubated at
37 ◦C over-night.
Two-hundred µL of each ETA sample were needed to perform standard cultures, whilst the
remaining volume of sample (minimum 200 µL) was sonicated in ultrasonic cleaning equipment
(Branson 3510 E-MT; Bransonic, Danbury, CT, USA) for 5 min at 40 KHz to disaggregate biofilms,
before undergoing serial dilutions and plating as aforementioned. Bacterial growth was quantified and
reported as log10 colony-forming units per milliliter (log CFU/mL). Microorganisms were identified
by mass spectrometry through a Microflex LT (Bruker Daltonik GmbH, Bremen, Germany) benchtop
instrument controlled by the FLEXCONTROL software (version 3.0; Bruker Daltonics). Spectra were
analysed with the MALDI BioTyper software (version 3.1; Bruker Daltonics) using the pre-processing
and Bio- Typer main spectrum (MSP) identification standard methods (mass range 2000–20,000 m/z)
against the default Bruker database. Accuracy of the identification was determined by a loga-rithmic
score value resulting from the alignment of peaks to the best matching reference spectrum. All bacterial
quantitative cultures were performed in duplicates.
Five tissue samples (80–120 mg each) from the five lobes of the lungs were excised and placed on
sterile vials. Lung biopsies were aseptically homogenized by using a glass tissue mortar, in a volume
of 0.9% NaCl solution to yield a 1:5 (w/v) suspension of ground tissue.
2.4. Microscopy Images Acquisition
To qualitatively assess biofilm clusters and planktonic bacteria, standard Gram staining and
confocal laser scanning microscopy (CLSM) were performed for both non-sonicated and sonicated
ETA samples. For Gram staining, the conventional timing and dies were used. Gram-stained slides
were inspected using a 100× oil objective on a DMRB microscope with equipped with a color camera.
ETA samples were immediately stained after extraction with the LIVE/DEAD®BacLight kit™
(BacLight kit™, Invitrogen, Barcelona, Spain), adding 1.5 µL SYTO9 and 1.5 µL popidium iodide
(PI) dyes in 1 mL PBS 1× during 15 min in the dark. Then, a very thin layer was smeared
onto the slide. Images were obtained with a Leica TCS SP5 laser scanning confocal system
(Leica Microsystems Heidelberg GmbH, Manheim, Germany) equipped with a DMI6000 inverted
microscope, and a 63× PL APO numerical aperture 0.7 oil immersion objective was used. SYTO® 9
(Invitrogen, Barcelona, Spain) and PI images were acquired sequentially using 488, 561 nm laser lines,
AOBS as beam splitter, and emission detection ranges 500–550, 570–620 nm, respectively. The confocal
pinhole was set at 1 Airy unit and pixel size was 160 nm.
2.5. Statistical Analysis
Categorical variables are reported in percentage (%) and continuous variables as mean ± SD if
normally distributed. Paired samples were compared using the paired t-test. Spearman correlation
coefficient analyses were performed to determine associations between quantitative variables. For the
correlation between ETA and lung tissue burden, we selected samples from animals that did not
receive nebulized antibiotics, because of the extreme high antimicrobial activity in the ETA samples.
The sensitivity, specificity, and positive and negative predictive value of microbiologic cut-offs were
calculated with two-by-two contingency tables using standard formulae, when paired ETA and BAL
samples were available. All statistical analyses were performed using IBM SPSS Statistics version 22.0
(Armonk, NY, USA). Two-tailed testing was used and p < 0.05 was considered statistically significant.
3. Results
3.1. Population
We analyzed thirty-three pigs, 27 and 6 belonged to P. aeruginosa and MRSA pneumonia models,
respectively. Twenty-four pigs were intrabronchially challenged with either P. aeruginosa or MRSA
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and included in studies to test pneumonia treatments. In contrast, nine pigs were challenged with the
bacterial suspension instilled into the oropharynx for VAP preventive studies (Table 1).
Table 1. Number of animals, microorganism, instillation model, and treatment of the different studies.
Study Pigs (n) InoculatedMicroorganism
Bacterial
Instillation ETA (n) BAL (n) Treatment
Study 1 15 P. aeruginosa Lungs 39 23 Untreated controls vs. Nebulizedaminoglycoside vs. IV carbapenem
Study 2 4 MRSA Oropharynx 10 0 Untreated controls vs. Monoclonal antibody
Study 3 7 P. aeruginosa Lungs 16 14 Untreated controls vs. IV cephalosporin
Study 4 5 P. aeruginosa Oropharynx 14 12 Untreated controls vs. Monoclonal antibody
Study 5 2 MRSA Lungs 6 6 Untreated controls vs. IV lipoglycopeptide
IV: Intravenous; Dosages: aminoglycoside (300 mg/kg every 6 h), carbapenem (25 mg/kg every 8 h), cephalosporin
(50 mg/kg every 8 h), Monoclonal antibody against P. aeruginosa (15 mg/Kg single dose), lipoglycopeptide
(25 mg/kg every 24 h). Study 2 only comprised untreated pigs.
3.2. Samples Collected
Overall we obtained 55 BAL and 85 ETA, 69 (81%) from P. aeruginosa versus 16 (19%) from MRSA
challenged pigs, 61 (72%) belonged to pigs intrabronchially challenged versus 24 (28%) obtained from
the oropharynx instilled model. Among the 85 ETA samples: 33, 25, and 27 were obtained at 24, 48,
or 72 h (autopsy) after bacterial challenge, respectively. A total of 36 versus 49 ETA samples were
obtained from untreated versus treated pigs, respectively (Table 1).
3.3. Standard Versus Sonicated Cultures
No differences were found on the qualitative or semi-quantitative VAP microbial diagnosis when
comparing sonicated versus non-sonicated ETA samples, independent of whether the cut-off used was
5 or 6 log CFU/mL. In contrast, in 81 ETA quantitative bacterial cultures (4 were uncountable) we
found that bacterial burden (log CFU/mL) was significantly higher in sonicated versus non-sonicated
ETA cultures (4.42 ± 2.58 vs. 4.18 ± 2.5 respectively; p < 0.001) (Figure 1).
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Figure 1. Bland–Altman plot showing the differences between sonicated and non-sonicated
endotracheal aspirate (ETA) paired samples (Mean ± SD). Eighty-one quantitative ETA cultures
were performed twice: before and after sonication. Each single dot represents the difference between
bacterial burden of sonicated minus non-sonicated ETA, using non-sonicated values in the X axis.
Of notice, 52 out of 81 (64%) dots were allocated above zero, 21 out of 81 (26%) at zero, and 8 out of
81 (10%) below zero. Mean difference ± SD was 0.2 ± 0.3 log CFU/mL (p < 0.001).
In particular, we analyzed 69 vs. 16 ETA samples obtained from P. aeruginosa vs. MRSA models,
respectively. Sonicated ETA samples presented higher P. aeruginosa burden versus non-sonicated ones.
However, the increase in MRSA burden after sonication did not reach statistical significance (Table 2).
Microorganisms 2017, 5, 62 6 of 13
Along time assessments, sonicated vs. non-sonicated ETA consistently presented higher bacterial
burden at 24, 48, and at 72 h after bacterial challenge (Table 2).
Table 2. Comparison of non-sonicated versus sonicated ETA bacterial load by microorganism,
instillation model and time of assessment.
Non-Sonicated
ETA (log CFU/mL)
Sonicated ETA
(log CFU/mL) p-Value
Inoculated microorganism P. aeruginosa (n = 69) 4.03 ± 2.58 4.25 ± 2.79 p < 0.001
MRSA (n = 16) 4.82 ± 2.04 5.17 ± 1.52 0.159
Bacterial instillation
Lungs (n = 61) 4.10 ± 2.50 4.35 ± 2.65 p < 0.001
Oropharynx (n = 24) 4.37 ± 2.53 4.61 ± 2.42 0.156
Time of assessment
(hours after bacterial challenge)
24 h (n = 33) 5.24 ± 1.65 5.45 ± 1.71 p < 0.001
48 h (n = 25) 3.67 ± 2.69 3.79 ± 2.82 0.019
72 h (n = 27) 3.30 ± 2.84 3.62 ± 2.89 0.052
Sonication also increased ETA bacterial burden when the bacterial challenge was intrabronchial.
In contrast, no difference in bacterial burden was found between sonicated and non-sonicated
quantitative cultures for the 9 pigs that received bacterial instillation of the oropharynx (Table 2).
3.4. Sensitivity and Specificity
The sensitivity (Se) and the specificity (Sp) of sonicated and non-sonicated quantitative cultures of
ETAs used for the diagnosis of pneumonia were determined using BAL ≥ 4 log CFU/mL as a gold
standard. The Se/Sp analysis were performed for both ETA cut-off points: ≥5 log CFU/mL and
≥6log CFU/mL. No improvement in Se/Sp was detected after ETA sonication when the ETA cut-off was
≥5 log CFU/mL. In contrast, Se improved from 75%, in non-sonicated samples, to 87.5% after sonication.
Additionally, Sp decreased from 83 to 70.2% when the ETA cut-off was≥6 log CFU/mL (Table 3).
Table 3. Effect of ETA sonication on the diagnosis of pneumonia using BAL ≥ 4 log CFU/mL as
gold standard.
ETA cut-off Se Sp PPV NPV PLR NLR
(95%CI) (95%CI) (95%CI) (95%CI) (95%CI) (95%CI)
Non-sonicated ETA
≥5 log CFU/mL 100 46.8 24.2 100 1.88 Undefined
(100–100) (32.5–61.1) (9.6–38.9) (100–100) (1.44–2.46)
≥6 log CFU/mL 75.0 83.0 42.9 95.1 4.41 0.30
(65.6–100) (72.2–93.7) (16.9–68.8) (88.5–100) (2.09–9.3) (0.09–1.01)
Sonicated ETA
≥5 log CFU/mL 100 40.4 22.2 100 1.68 Undefined
(100–100) (26.4–54.5) (8.6–35.8) (100–100) (1.33–2.12)
≥6 log CFU/mL 87.5 70.2 33.3 97.1 2.94 0.18
(64.6–100) (57.1–83.3) (13.2–53.5) (91.4–100) (1.76–4.90) (0.03–1.12)
Se: sensitivity; Sp: Specificity; PPV: positive predictive value; NPV: negative predictive value; PLR: positive
likelihood ratio; NLR: negative likelihood ratio; CFU: Colony-forming units; ETA: endotracheal aspirate.
A likelihood ratio is a probability that a subject with a positive (or negative) test has the disease in question.
If the PLR is over 5 and the NLR is under 0.10, it may be concluded that it is essential for a diagnosis and of high
validity for use in routine clinical practice. A likelihood ratio of 2.0 corresponds to an approximately +15% increase
in probability, which is considered a slight increase. A likelihood ratio of 5.0 corresponds to an approximately +30%
increase in probability, which is considered a moderate increase.
In 55 cases, a moderate correlation was found to exist between non-sonicated and sonicated
ETA and BAL bacterial loads. However, the non-sonicated vs. sonicated ETA-BAL correlation did
not significantly improve after sonication (r = 0.51 and r = 0.56, respectively; p = 0.75) (Figure 2).
The correlation between non-sonicated vs. sonicated ETA and lung tissue bacterial load did not
significantly improve after sonication either (r = 0.52 and r = 0.57, respectively; p = 0.86), although this
last analysis included only 15 cases (Figure 3).
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after sonication (Figure 4). Increased amounts of free-floating bacteria were identified, particularly 
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samples (B). The histograms represent the number of ETA (on the top) or BAL (right) on each
bacterial concentration. Moderate correlation was found between non-sonicated and sonicated ETA
and BAL(r = 0.51 and r = 0.56, respectively; p = 0.75). ETA and BAL cut-off was 6 log CFU/mL and
4 log CFU/mL, respectively. After sonication the number of true positives samples increased from
6 (11%) to 7 (13%) out of 55 samples.
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Figure 3. Correlation between ETA and lung tissue bacterial burden. Of note, in 15 cases a moderate
correlation was found between non-sonicated or sonicated ETA and lung tissue bacterial burden
(r = 0.52 and r = 0.57, respectively; p = 0.86).
3.5. Imaging Biofilms
P. aeruginosa biofilm aggregates were identified by optical microscopy and CLSM before and after
sonication (Figure 4). Increased amounts of free-floating bacteria were identified, particularly on Gram
staining, after ETA sonicatio at 24, 48, and 72 h after bacterial challenge (Figure 5).
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sonication in P. aeruginosa and MRSA infection models. Of note, viable bacteria (in green) stained
with the SYTO 9, a green Fluorescent Nucleic Acid Stain, were visible. Dead bacteria (in red) stained
with the propidium iodide (PI) were barely detected. The nucleus and cytoplasm of eukaryotic cells
from the pig were also stained nonspecifically with the PI and SYTO 9 (large red and green blotches).
(A) vs. (B) correspond to non-sonicated vs. sonicated ETA (5.14 vs. 6.20 log CFU/mL) after 72 h of
P. aeruginosa instillation with biofilm clusters visible (white arrow). Similarly, (C) vs. (D) correspond
to non-sonicated vs. sonicated ETA (1.38 vs. 1.88 log CFU/mL) after 72 h of MRSA instillation with
biofilm clusters and free-floating cocci (white arrows), respectively. (A,B) images belong to a pig treated
with IV cephalosporin and (C,D) to a pig treated with IV lipoglycopeptide. (E) 3D reconstruction of
a Gram-negative bacilli biofilm cluster (Imaris, Bitplane, Oxford instruments Company, Abingdon, UK).
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Figure 5. Optical microscopy images of Gram stained ETA before and after sonication. Images
(A) vs. (B), (C) vs. (D) and (E) vs. (F) correspond to non-sonicated vs. sonicated ETA at 24, 48, and 72 h,
respectively. Biofilm aggregates (white arrow) were observed before and after sonication. In contrast,
free-floating bacteria were mainly detected after sonication (black arrow).
4. Discussion
Optimizing VAP diagnosis has become a top priority because of the increasing prevalence of
multidrug resistant pathogens in ICUs and the scarce availability of new therapy options. In this
context, it is crucial to have a rapid and accurate microbiological diagnosis in order to improve
treatment guidance. Our study deals with the ability of microorganisms to form biofilms within
respiratory secretions and highlights sonication as a method to disaggregate them before applying
either standard, rapid, or high throughput diagnostic technologies in order to improve pathogen
identification. Smooth sonication is the gold standard for disaggregating biofilms in sputum of cystic
fibrosis patients [29,30], prosthetic joint devices [20], catheters [31,32], or endotracheal tubes [24,33].
In line with previous findings, we demonstrated that bacterial counts were higher in sonicated versus
non-sonicated ETA samples, and this finding was consistent at different time points.
A BAL threshold ≥4 log CFU/mL has been used instead of histology as a gold standard [34]
for the sensitivity and specificity analyses in previous studies [9]. We found 75% Se and 83% Sp
of non-sonicated ETA, using the cut-off ≥6 log CFU/mL. Our Se/Sp values are higher than
54%/75% reported by Valencia et al. [8], but in line with those reported by Morris et al., or by
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Jourdain et al. using BAL samples [35]. Differences between studies could be influenced by the
gold standard used or by sample size, which was superior in the Valencia et al study [8]. Interestingly,
in our study, sensitivity was notably increased after sonication (87.5%) and specificity (70%) was
similar [8] or even superior to other previous studies [9]. This increase in sensitivity was only apparent
when the cut-off of ETA burden was ≥6 log CFU/mL. This stirs the debate about the most appropriate
ETA cut-off. Those defending a lower cut-off point opt for greater sensitivity at the expense of losing
specificity, and vice versa. Our results suggest that with a cut-off ≥6 log CFU/mL, ETA sonication
grants higher sensitivity whilst maintaining high specificity. Subsequently, further investigations
should prospectively investigate the utility of sonication in routine clinical diagnostics.
Further study is required to determine whether sonication is an effective adjunct for both
P. aeruginosa and MRSA ETA cultures. Our previous results indicated that both P. aeruginosa and
MRSA formed biofilms in ETTs and also in respiratory secretions accumulated within the ETT [23,24].
Interestingly, Hola V. and coauthors investigated the microbial composition in urinary catheters by
applying sonication and found that it improved diagnosis of urinary tract infections, especially when
strong biofilm producers were present [31]. We found that ETA sonication increased bacterial counting
of P. aeruginosa but did not reach a statistically significant increase for MRSA growth. The reason
for this could be either attributed to a better biofilm formation capability of P. aeruginosa, to a lower
number of animals challenged with MRSA, or to a combination of both.
The latest clinical guidelines for the diagnosis and treatment of BAI strongly recommend the use
of imaging techniques [21]. Recent investigations have evidenced the presence of biofilms by CLSM in
BAL samples of children with non-cystic fibrosis bronchiectasis [22]. In the present study we confirmed
that P. aeruginosa biofilms are also found in ETA samples from a pig model of pneumonia. Importantly,
biofilms were identified by two independent microscopy techniques (Optical microscopy-Gram stain
or CLSM-Live/Dead Kit) even after sonication. Our findings are relevant as they imply that we may
be sub-optimally utilizing existing diagnostic technology if we do not disaggregate bacteria from their
biofilms before ETA culture. Considering the latest advancements in point-of-care diagnosis [36] and
that biofilm forming species of the respiratory microbiome can trigger pathogen growth [22,37,38],
this seems the appropriate time to reconsider the diagnosis of biofilms in respiratory samples from
intubated ICU patients with suspicion of VAP.
Several limitations should be addressed within our study. First, interestingly, the study comprised
different pneumonia models that differed by the microorganism, the type of bacterial challenge, and the
treatment administered. This was especially a limitation for sub-analyses as it decreased the sample
size in specific cases. Second, BAL missing samples or the exclusion of lung tissue samples from
pigs treated with nebulized antibiotics limited the Se/Sp and the power of the correlation analyses.
Ultimately, the beneficial effects of sonication was only detectable in quantitative cultures, which are
not the routine technique used for microbial diagnosis [39]. Nevertheless, our results provide enough
evidence that P. aeruginosa biofilms are present in ETA samples, even after sonication, and this can
influence the sensitivity of not only conventional, but also high throughput and rapid diagnostics.
5. Conclusions
Sonication of ETA improves the detection of P. aeruginosa within biofilms, improving sensitivity
and maintaining specificity for VAP microbiological diagnosis in a pig model of pneumonia.
Its utility in routine clinical laboratory or before rapid or high throughput technologies needs to
be prospectively investigated.
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